Form 10-Q · Quarterly report
Quest Diagnostics 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0001022079
- Accession no.
- 0001022079-26-000070
Summary
Quest Diagnostics reported second-quarter 2026 net revenues of $3.04 billion, up 10.2% year over year, and diluted earnings per share of $2.84, up 15.0%, with test volume growth of 13.1% attributed in part to a new relationship with Corewell Health and increased testing at Fresenius Medical Care dialysis clinics. The company said the more routine test mix from those relationships lowered revenue per requisition by 2.8%.
Key points
- Quest Diagnostics reported second-quarter 2026 total net revenues of $3.04 billion, up 10.2% from $2.76 billion a year earlier, with diagnostic information services revenue up 10.3%.
- Diluted earnings per share attributable to Quest Diagnostics rose 15.0% to $2.84 for the quarter and 15.2% to $5.08 for the six months ended June 30, 2026.
- DIS test volume rose 13.1% in the quarter, of which about 9 percentage points came from a new relationship with Corewell Health to provide Collaborative Lab Solutions and increased lab testing at Fresenius Medical Care dialysis clinics in the United States; excluding those, organic volume grew about 4%.
- Revenue per requisition fell 2.8% in the quarter, which Quest attributed to the more routine test mix from the Corewell Health and Fresenius Medical Care relationships; excluding those, it rose about 3%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2.Management’s Discussion Results of Operations The following tables set forth certain results of operations data for the periods presented: Three Months Ended June 30, Six Months Ended June 30, 2026 2025 $ Change % Change 2026 2025 $ Change % Change (dollars in millions, except per share amounts) Net revenues: DIS business $ 2,978 $ 2,699 $ 279 10.3 % $ 5,810 $ 5,288 $ 522 9.9 % DS businesses 65 62 3 4.3 128 125 3 2.5 Total net revenues $ 3,043 $ 2,761 $ 282 10.2 % $ 5,938 $ 5,413 $ 525 9.7 % Operating costs and expenses and other operating income: Cost of services $ 2,016 $ 1,818 $ 198 10.9 % $ 3,969 $ 3,607 $ 362 10.0 % Selling, general and administrative 529 486 43 9.0 1,033 962 71…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.